Personalised versus non-individualised case-based CME: A randomised pilot study.
Continuing medical education
case-based learning
individualised learning
online CME
prostate cancer
Journal
Journal of European CME
ISSN: 2161-4083
Titre abrégé: J Eur CME
Pays: United States
ID NLM: 101691422
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
5
12
2022
pubmed:
6
12
2022
medline:
6
12
2022
Statut:
epublish
Résumé
The PinPoint Case Platform (PPCP) offers independent online case-based CME. To align with personal learning needs, a functionality of needs assessments ("QuickScan") was developed, directing users to follow personalised case journeys. A randomised study was conducted, comparing its effectiveness, time efficiency and user experience with a format of non-individualised case-based learning. Forty-two residents in urology from five European countries were randomly assigned to follow non-individualised case-based learning (control group) or a needs assessment plus personalised case journeys on different topics in prostate cancer. After performing a pre- and post-assessment, both groups showed a similar increase in test scores (Mann-Whitney
Identifiants
pubmed: 36465494
doi: 10.1080/21614083.2022.2153438
pii: 2153438
pmc: PMC9718550
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2153438Informations de copyright
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Déclaration de conflit d'intérêts
AB has received meeting support and honorarium from Sanofi, Astellas, Janssen, Bayer and AAA Pharmaceutical. NRMM, JS, JT, FVdA and TZ declare no competing interests related to the present study. NH and JY are employees of Ismar Healthcare. LS, LVR and HS are partners in Ismar Healthcare and e-HIMS. MJS has received honoraria from Astellas for lectures/chairmanship. BFT has received grants/research supports or honoraria from Amgen, Astellas, Janssens, Ferring, Sanofi, Bayer and Myovant. MCM has received speaker and/or consultancy honorary from Apogepha, Astellas, Dr. Willmar Schwabe, GSK and Sanofi-Aventis.
Références
World J Urol. 2021 Jun;39(6):1997-2003
pubmed: 32860535
Educ Prim Care. 2013 Feb;24(2):138-40
pubmed: 23498584
Am J Prev Med. 2010 Nov;39(5):472-8
pubmed: 20965387
Plast Surg (Oakv). 2014 Summer;22(2):75-8
pubmed: 25114616
BMC Med Educ. 2020 Oct 20;20(1):374
pubmed: 33081765
Int J Technol Assess Health Care. 1986;2(1):53-63
pubmed: 10300718
JAMA. 2005 Sep 7;294(9):1043-51
pubmed: 16145024
Int J Technol Assess Health Care. 2005 Summer;21(3):380-5
pubmed: 16110718
Insights Imaging. 2019 Jul 17;10(1):68
pubmed: 31312978
J Contin Educ Health Prof. 2015 Spring;35(2):131-8
pubmed: 26115113
Adv Med Educ Pract. 2019 Sep 11;10:805-812
pubmed: 31572042
BMC Med Educ. 2010 Jun 10;10:42
pubmed: 20537144
BMJ. 2004 Apr 24;328(7446):999-1001
pubmed: 15105326
Acad Med. 2018 Jan;93(1):104-112
pubmed: 28658022
J Gen Intern Med. 2006 May;21(5):419-23
pubmed: 16704381
Indian J Psychol Med. 2020 Sep 29;42(5 Suppl):97S-102S
pubmed: 33354073
Pain Physician. 2020 Aug;23(4S):S367-S380
pubmed: 32942794
Postgrad Med J. 2016 Apr;92(1086):217-22
pubmed: 26850504
Clin Cardiol. 2017 Jul;40(7):455-460
pubmed: 28139836